New York, NY -- (SBWIRE) -- 01/02/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Golden Star Resources Ltd. (USA)(NYSEMKT:GSS), Citigroup Inc(NYSE:C), Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), Synovus Financial Corp.(NYSE:SNV)
Golden Star Resources Ltd. (USA)(NYSEMKT:GSS)’s reported the decrease of -2.22% to close at $0.440 with the overall traded volume of 3.68M shares. Its market capitalization on last close reached to $114.01 million. Its intraday-low price was $0.44 and its hit its day's highest price at $0.48.
Golden Star Resources Ltd, (Golden Star) is an international gold mining and exploration company producing gold in Ghana, West Africa. The Company also conducts gold exploration in other countries in West Africa and in South America. Golden Star owns controlling interests in several gold properties in southwest Ghana.
Should GSS a Buy or Sell Now? Find Out Here
Citigroup Inc(NYSE:C) increase 0.37% settle at $52.11. Its total traded volume during last trading session was 10.71M shares. The overall market worth of this company is about $158.05B. The 52 week range of the stock remained $40.28 - $53.68, while its day's lowest price was $51.81 and its hit its day's highest price at $52.12.
Citigroup Inc. (Citigroup) is a global diversified financial services holding company whose businesses provide consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services and wealth management.
What C Charts Are Signaling for Traders? Find Out Here
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA)’s reported the decrease of -0.51% to close at $5.85 with the overall traded volume of 3.62M shares. Its market capitalization on last close reached to $1.28 billion. Its intraday-low price was $5.83 and its hit its day's highest price at $5.97.
Arena Pharmaceuticals, Inc. (Arena) is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors. Its wholly owned subsidiary, Arena Pharmaceuticals GmbH (Arena GmbH), has granted Eisai Inc., rights to commercialize BELVIQ in the United States.
Should ARNA a Buy or Sell Now? Find Out Here
Synovus Financial Corp.(NYSE:SNV) increase 1.41% settle at $3.60. Its total traded volume during last trading session was 3.60M shares. The overall market worth of this company is about $3.50B. The 52 week range of the stock remained $2.41 - $5.85, while its day's lowest price was $3.55 and its hit its day's highest price at $3.61.
Synovus Financial Corp. ( Synovus) is a financial services and a bank holding company. The Company provides integrated financial services, including commercial and retail banking, financial management, insurance and mortgage services to its customers through 29 locally-branded banking divisions of its wholly-owned subsidiary bank, Synovus Bank, and other offices in Georgia, Alabama, South Carolina, Florida and Tennessee.
What SNV Charts Are Signaling for Traders? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)